ArticleEuropean urology open science2026
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials.
Leo Bickley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.